Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBlue Cross Blue Shield - Texas Prior Auth Codes | …
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    DraftBlue Cross Blue Shield - TexasPolicy N/A

    2026 Commercial Prior Authorization Codes for Administrative Services Only

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Texas policy alerts

    Know when Blue Cross Blue Shield - Texas releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    List of CPT/HCPCS codes and service categories for which prior authorization may be required for Blue Cross Blue Shield of Texas commercial administrative services; intended for providers and administrative staff who submit prior authorization requests.

    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    Policy2026 Commercial Prior Authorization Codes for Administrative Services Only
    Policy CodePolicy N/A
    Change TypeMinor / informational update
    Effective DateN/A
    Next Review DateN/A
    Key ActionInitiate prior authorization via the searchable PDF (CTRL+F), Blue ApprovrSM, or the prior authorization number on the member's ID card; use vendor contacts (Carelon, Alacura) as indicated per code.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    dozens+codes enumerated
    Carelonprimary PA vendor
    20+code groups shown
    multiplehome infusion codes

    Coverage and Authorization Requirements

    Coverage and authorization guidance

    Prior authorization may be required for the listed services; check member benefits for coverage and follow vendor routing for authorization.

    Prior authorization may be required for the CPT/HCPCS codes listed in this document; presence on the list does not guarantee coverage — confirm member benefits before providing service.

    Prior authorization requirement (codes listed)

    Codes listed are identified as requiring prior authorization and mapped to Carelon and service category.

    Provider must obtain prior authorization for the CPT codes shown where the 'Carelon' designation is listed as the managing/authorization entity before performing the service.

    Prior authorization requirement — code list

    Codes listed require prior authorization via the named vendor (Carelon).

    All CPT/HCPCS codes in the molecular and advanced imaging sections that indicate 'Carelon' require submission of a prior authorization request to Carelon as specified in the list.

    Prior authorization requirements by code

    Codes listed require prior authorization; the assigned authorization vendor is indicated per code.

    Examples

    • Code 93313 — prior authorization required; auth entity: Carelon.
    • Code 95965 — prior authorization required; auth entity: Carelon; effective date noted (Add effective 1/1/2026).
    • Code 36516 — prior authorization required; auth entity: BCBSTX.
    • Code B4150 — prior authorization required when billed for home infusion/enteral formula; auth entity: BCBSTX.

    Prior authorization requirement — code list (home infusion/enteral/parenteral)

    This section enumerates codes that require prior authorization when billed for home infusion therapy, enteral or parenteral nutrition, pumps, supplies, and home infusion per diem services.

    HCPCS S-codes and B-codes listed for home infusion, enteral formulas, parenteral nutrition premixes, infusion pumps, and related per-diem services require prior authorization as indicated; many entries show BCBSTX as the authorization manager for these home infusion/enteral/parenteral services.

    Codes requiring prior authorization and vendor assignments (excerpt)

    The listed HCPCS/CPT codes in these chunks are identified as requiring prior authorization and are mapped to internal assignments/vendors where specified.

    The S-code list (e.g., S9339, S9340, S9341, S9343, ... A0430, S9960) requires prior authorization when used for home infusion/home injectable therapy and certain medical transport; many of these entries map to BCBSTX for authorization routing.
    Molecular genetic CPT codes (example range 81120–81187 and related entries) listed in this section require prior authorization and are routed to Carelon for review as indicated.

    Prior authorization list (excerpt)

    Listed tests require prior authorization through Carelon; entries map code to gene/test type (e.g., full sequence, known familial variant, common variants, expanded allele evaluation). No clinical eligibility criteria included in this excerpt.

    Molecular genetic test codes shown (examples: 81180–81187, 81229, 81230, etc.) require prior authorization and identify Carelon as the reviewer/authorization vendor; each code is mapped to specific gene/test descriptions (full sequence, known familial variant, duplication/deletion analysis, promoter methylation, MSI, etc.).

    Authorization requirements for listed CPT codes

    Codes listed in this section require prior authorization; many entries indicate Carelon as the reviewer.

    Selected molecular CPT codes (e.g., 81254–81261, 81319–81328) are listed as requiring prior authorization; Carelon is identified adjacent to numerous codes as the authorization/review entity.

    Coverage stance for listed molecular genetic tests

    Prior authorization required for the following molecular genetic and molecular pathology CPT codes and associated analyses through Carelon.

    Codes 81319, 81324, 81336 (examples shown) require prior authorization via Carelon for the specified gene analyses (duplication/deletion variants, full sequence analysis, etc.).
    Molecular pathology procedure level codes (81400–81405) and higher-level genomic panel codes listed require prior authorization via Carelon as indicated in the list.

    Coverage criteria by panel/code

    Coverage requires that condition-specific genomic panels include the listed minimum genes and analyses; panels are mapped to clinical indications (examples):

    81410 — Aortic dysfunction/dilation genomic sequence analysis panels must include sequencing of at least 9 genes (including FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, MYLK); prior authorization routed to Carelon.
    81431 / 81432 — Hearing loss panels must include sequencing of at least 60 genes (examples: CDH23, GJB2, MYO7A, MYO15A, OTOF, etc.) and, where indicated, copy number analyses for STRC and DFNB1 deletions (GJB2/GJB6); prior authorization routed to Carelon.
    81440 — Nuclear-encoded mitochondrial gene panels must include analysis of at least ~100 genes (examples listed) and require prior authorization via Carelon.

    Prior authorization requirement for listed molecular/genetic tests

    Listed molecular/genetic CPT and PLA codes require prior authorization and are routed to Carelon for review.

    Prior authorization is required for the molecular/genetic CPT and PLA codes listed (examples include 81450–81459 panels and related PLA/U-codes); submit prior authorization requests to Carelon for review as indicated.

    Prior authorization requirement for listed molecular/genetic tests

    Codes and test descriptions requiring prior authorization

    PLA/U-code group examples (0034U, 0036U, 0037U, 0047U, 0048U, 0050U, etc.) are designated as requiring prior authorization and identify Carelon as the authorization entity in the list.

    Prior authorization list (no detailed criteria in this excerpt)

    This section enumerates molecular/genetic lab tests that require prior authorization and indicates Carelon as reviewer. Specific clinical coverage criteria are not detailed in this excerpt.

    U-code and molecular genetic test listings in this segment (e.g., 0170U, 0171U, 0203U, 0205U, 0244U, 0253U, etc.) require prior authorization as noted; Carelon is named repeatedly as the reviewer, and the list includes tests across oncology, neurology, psychiatry, reproductive medicine and other specialties.

    Prior authorization listing (segment 234-253)

    Codes listed require prior authorization via Carelon. Specific clinical criteria, medical necessity, or coverage determinations are not provided in this excerpt.

    All U-codes and specified molecular genetic tests in this segment (e.g., 0286U–0410U examples shown) require prior authorization through Carelon; the entries map each code to its gene/test type or panel description but do not include clinical eligibility rules in this excerpt.

    Prior authorization listing (examples)

    Listed molecular genetic laboratory procedures require prior authorization through Carelon; examples include oncology NGS panels, pharmacogenomic panels, prenatal cfDNA tests, transplant donor-derived cfDNA quantification, and genome sequencing for rare conditions.

    Examples (selected)

    • 0401U — targeted variant genotyping (cardiac/coronary risk score) requires prior authorization; auth entity: Carelon.
    • 0439U / 0440U — drug metabolism / pharmacogenomics panels (33 genes including CYP2D6 deletion/duplication analysis) require prior authorization; auth entity: Carelon.
    • 0469U — whole genome sequencing for rare/constitutional disorders (fetal samples, ROH, CNV, UPD analysis) requires prior authorization; auth entity: Carelon.

    CPT / HCPCS / U-code Examples

    Examples of listed CPT/HCPCS/U codesmixed
    70471Computed tomographic angiography (CTA), head and neck, with contrast; managed by Carelon; add effective 7/1/2026
    70472CT cerebral perfusion analysis with contrast including image postprocessing; managed by Carelon; add effective 7/1/2026
    0628UNephrology genomic analysis renal disease panel, NGS 449 genes; managed by Carelon; add effective 7/1/2026
    0630UOncology (breast) mRNA gene expression profiling by microarray of 80 genes; managed by Carelon; add effective 7/1/2026
    77436Surface radiation therapy; treatment planning and simulation-aided field setting; managed by Carelon; add effective 7/1/2026
    Imaging codes (sample)mixed
    70496Computed tomographic angiography head with contrast including noncontrast images and postprocessing; managed by Carelon
    70551MRI brain (including brain stem) without contrast; managed by Carelon
    71271CT thorax low dose for lung cancer screening without contrast; managed by Carelon
    Advanced imaging CPT groups in fragmentCPTCovered
    73206-73225Magnetic resonance/CT imaging of upper extremity variants (with/without contrast, postprocessing) as listed
    73700-73725Computed tomography / magnetic resonance imaging of lower extremity variants and MRA (with/without contrast)
    74150-74183CT/MR abdomen and pelvis series (without/with contrast, CTA) and related postprocessing
    74261-74263CT colonography diagnostic/screening including image postprocessing
    74712-74713Fetal MRI (single and additional gestations)
    75557-75574Cardiac MRI/CT procedures including stress, velocity mapping, coronary calcium scoring and CTA
    75635CTA abdominal aorta and bilateral iliofemoral runoff with postprocessing
    76376-76380, 763903D rendering, image postprocessing, limited CT follow-up, MR spectroscopy
    77046-77049, 77078, 77084MR elastography and related imaging studies
    78012-78020, 78070-78075Thyroid/parathyroid/adrenal and related nuclear imaging procedures
    1–10 of 14
    1/2
    Myocardial PET imagingCPTCovered
    78429Myocardial imaging PET metabolic evaluation single study with concurrently acquired CT transmission scan
    78430Myocardial imaging PET perfusion study single study at rest or stress with concurrently acquired CT transmission scan
    PET whole/limited area codesCPTCovered
    78811PET imaging; limited area
    78812PET imaging; skull base to mid-thigh
    78813PET imaging; whole body
    Echocardiography (transesophageal)CPTCovered
    93313Transesophageal echocardiography; real-time with image documentation (2D)
    93314Transesophageal echocardiography; image acquisition, interpretation and report only
    MEG/CT perfusionCPTCovered
    95965Magnetoencephalography (MEG) recording and analysis; spontaneous brain magnetic activity
    95966MEG for evoked magnetic fields, single modality
    0042TCerebral perfusion analysis using CT with contrast and parametric maps
    Enteral nutrition/home infusion HCPCSHCPCSCovered
    B4103Enteral formula for adults used to replace fluids and electrolytes; 500 ml = 1 unit
    B4150Enteral formula nutritionally complete with intact nutrients; 100 kcal = 1 unit
    Enteral formula HCPCS codes (examples shown)HCPCSCovered
    B4103Enteral formula — adult/pediatric clear liquids; unit definitions
    B4149Enteral formula — blenderized natural foods; 100 calories = 1 unit
    B4150Enteral formula — nutritionally complete with intact nutrients
    B4152Enteral formula — calorically dense (≥1.5 kcal/mL)
    Parenteral nutrition HCPCS codes (examples shown)HCPCSCovered
    B4164Parenteral nutrition solution: dextrose ≤50% (Homemix)
    B4189Parenteral nutrition compounded amino acid/carbohydrates with electrolytes, trace elements, vitamins — premix (10–51g protein)
    B4193Parenteral nutrition premix (52–73g protein)
    B4197Parenteral nutrition premix (74–100g protein)
    B4199Parenteral nutrition premix (>100g protein)
    Infusion pump and device codesmixedCovered
    B9002Enteral nutrition infusion pump
    B9004Parenteral nutrition infusion pump — portable
    E0781Ambulatory infusion pump — electric or battery operated
    K0455Infusion pump for uninterrupted parenteral administration (e.g., epoprostenol)
    Home infusion per diem and service codesHCPCSCovered
    S5497Home infusion therapy — catheter care/maintenance; includes administrative services; per diem
    S5501Home infusion therapy — catheter care/maintenance complex (more than one lumen); per diem
    S9340Home therapy; Enteral Nutrition; administrative services and supplies; per diem
    S9343Home Therapy; Enteral Nutrition via pump/bolus; administrative services and supplies; per diem
    Selected home infusion S-codes and descriptionsHCPCSCovered
    S9340Home infusion therapy, intermittent chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and supplies and equipment (drugs and nursing visits coded separately), per diem
    S9341Home infusion therapy, intermittent chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and supplies and equipment (drugs and nursing visits coded separately), per diem (enteral nutrition via gravity noted)
    S9364Home infusion therapy Total Parenteral Nutrition (TPN); administrative services, pharmacy, care coordination and supplies including standard TPN formula (do not use with S9365-S9368 using daily volume scales)
    Molecular genetic lab testing examplesCPTCovered
    81162BRCA1/BRCA2 gene analysis; full sequence analysis and full duplication/deletion analysis
    81170ABL1 gene analysis; variants in kinase domain
    81180ATXN3/other spinocerebellar ataxia gene analyses (expanded allele detection)
    Molecular genetic test codes (excerpt)mixedCovered
    81180-81261 (partial range shown)Series of molecular genetic lab testing CPT-style codes with specific gene/test mappings (excerpt).
    Selected molecular genetic CPT codes and descriptions from sectionCPT
    81254Molecular genetic lab testing (example entries shown)
    81255FLT3 gene analysis; TKD variants (example)
    81256FLT3 gene analysis; TKD variants (alternate mapping shown)
    81257HBA1/HBA2 gene analysis; common deletions or variants
    81258HBA1/HBA2 gene analysis; known familial variant
    81259HBA1/HBA2 gene analysis; full gene sequence
    81266Comparative analysis using STR markers; patient and comparative specimen
    81270JAK2 V617F variant analysis
    81271HTT (Huntingtin) evaluation to detect expanded alleles
    81275KRAS exon 2 variants (codons 12 and 13)
    1–10 of 21
    1/3
    Molecular pathology CPT groups (81400-81405)CPTCovered
    81400Molecular Pathology Procedure Level 1 — identification of single germline variant (examples listed)
    81401Molecular Pathology Procedure Level 2 — 2-10 SNPs, methylated variant, somatic variant examples
    81402Molecular Pathology Procedure Level 3 — >10 SNPs, immunoglobulin/T-cell receptor rearrangements, UPD/STR analysis
    81403Molecular Pathology Procedure Level 4 — single exon sequence analysis, mutation scanning, examples of genes
    81404Molecular Pathology Procedure Level 5 — analysis of 2-5 exons, mutation scanning, characterization of dynamic mutations
    81405Molecular Pathology Procedure Level 6 — analysis of 6-10 exons, regionally targeted cytogenomic array, full gene sequences
    Listed molecular/genomic CPT codes and descriptionsCPT | mixedCovered
    81405Molecular genetic lab testing / molecular pathology procedure level 6
    81406Molecular pathology procedure level 7
    81407Molecular pathology procedure level 8
    81408Molecular pathology procedure level 9
    81410Genomic sequence analysis panels for aortic dysfunction/dilation (≥9 genes listed)
    81411Duplication/deletion analysis panel for aortic dysfunction (specific genes listed)
    81415Exome sequencing
    81416Comparator exome
    81417Re-evaluation of previously obtained exome
    81418Drug metabolism / pharmacogenomics (≥6 genes incl CYP2C19, CYP2D6)
    1–10 of 27
    1/3
    Selected CPT molecular panelsCPTCovered
    81450Genomic sequence analysis panel 5-50 genes; DNA or combined DNA/RNA analysis
    81451Hematolymphoid neoplasm panel; RNA analysis
    81455Solid organ or hematolymphoid neoplasm panel, 51+ genes; DNA or combined DNA/RNA analysis
    Selected PLA/unique molecular testsmixedCovered
    0001URed blood cell antigen typing DNA (35 antigens)
    0037UTargeted genomic sequence analysis solid organ neoplasm, 324 genes
    0048UTargeted sequencing of 468 cancer-associated genes
    sample U-codes (partial list)mixed
    0034UMolecular genetic lab testing (various descriptors listed)
    0036UExome/paired formalin-fixed paraffin-embedded tumor/normal sequence analyses
    0037UTargeted genomic sequence analysis solid organ neoplasm (324 genes) and related analyses
    codes flagged for removalmixed
    0131UTargeted mRNA sequence analysis panel — note: Remove effective 4/1/2026
    0132UTargeted mRNA sequence analysis panel — note: Remove effective 4/1/2026
    examples of listed U-codes and descriptionsmixed
    0170UMolecular genetic lab testing — predictive probability of ASD diagnosis / other specified assays
    0171UTargeted genomic sequence analysis panel / PMS2 mRNA sequence analysis etc.
    0203UmRNA gene expression profiling for autoimmune (IBD) 17 genes
    0205UAnalysis of 3 gene variants for neovascular AMD risk
    0211UCytogenomic constitutional genome-wide analysis / oncology pan-tumor NGS DNA/RNA
    0212UWhole genome and mitochondrial DNA sequence analysis for rare/heritable disorders
    0228UMultianalyte molecular profile for prostate cancer (urine)
    0244UDNA comprehensive genomic profiling 257 genes (solid organ)
    0253UEndometrial receptivity analysis RNA gene expression profile 238 genes
    0254UPreimplantation genetic assessment — 24 chromosome analysis per embryo
    1–10 of 13
    1/2
    Representative U-code group from segmentmixedCovered
    0286UMolecular genetic lab testing — variant described in list
    0326UTargeted genomic sequence analysis panel, cell-free circulating DNA, 83+ genes
    0340UAnalysis of minimal residual disease from plasma, patient-personalized assays
    0392UDNA and RNA NGS on FFPE tissue, 437 genes, includes immunotherapy response score
    0400UDNA/RNA NGS 437 genes; also used for expanded carrier screening (145 genes)
    0410UWhole genome sequencing with 5-hydroxymethylcytosine enrichment reported as cancer detected/not detected
    Selected U-codes (examples)mixed
    0401UTargeted variant genotyping, 9 genes — genetic risk score for coronary event
    0403UDNA and RNA NGS of 437 genes on FFPE tissue — interpretive oncology report
    0405UOncology NGS panel, algorithm reported as cancer signal detected/not detected
    Prenatal and transplant-related U-codesmixed
    0488UCell-free DNA noninvasive prenatal fetal antigen/Rh antigen detection
    0494UQuantification of donor-derived cell-free DNA for transplant monitoring
    inv-42: Effective date note
    Effective as listedThis code list reflects prior authorization requirements as of January 1, 2025
    Future additions notedSpecific codes include 'Add effective 4/1/2026' or 'Add effective 7/1/2026' as indicated in the list

    How to Request Prior Authorization

    Prior Authorization

    How to initiate prior authorization

    This file is a searchable PDF. Press CTRL+F to find a procedure code or service. Prior authorization requests for services handled by BCBSTX can be submitted three ways: use the searchable PDF (CTRL+F), Blue ApprovrSM, or call the prior authorization number on the member's ID card. For services handled by Alacura call 1-866-671-4834. For services handled by Carelon Medical Benefits Management call 1-866-455-8415 or access https://www.careloninsights.com/medical-benefitsmanagement/specialty-care.

    • How to initiate prior authorization: searchable PDF (CTRL+F), Blue ApprovrSM, or call the prior authorization number on the member's ID card.
    • Vendor contacts: Alacura — 1-866-671-4834; Carelon — 1-866-455-8415 or https://www.careloninsights.com/medical-benefitsmanagement/specialty-care.
    Prior Authorization

    Prior authorization assignment (Carelon)

    Many advanced imaging, PET, echocardiography/cardiac imaging, MEG/CT/MRI and related codes listed in the Medical/Surgical Procedures Requiring Prior Authorization table are assigned to Carelon for prior authorization review. When Carelon is listed beside a CPT/HCPCS code, prior authorization must be requested through Carelon.

    Definitions and Notes

    inv-72: 'TDI' indicated on member ID card for Fully Insured Members
    TDI identifier"TDI" will be indicated on the member's ID card for Fully Insured Members
    ApplicabilityApplies to fully insured members as noted in the document header
    Reference locationSee document title/header for the TDI note and effective/update information
    inv-73: Scope note — prior authorization code list
    List purposeThis list includes CPT and/or HCPCS codes for which prior authorization may be required
    Not exhaustiveLists are not exhaustive; absence from the list does not imply lack of prior authorization requirement
    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    Policy2026 Commercial Prior Authorization Codes for Administrative Services Only
    Policy CodePolicy N/A
    Change TypeMinor / informational update
    Effective DateN/A
    Next Review DateN/A
    Key ActionInitiate prior authorization via the searchable PDF (CTRL+F), Blue ApprovrSM, or the prior authorization number on the member's ID card; use vendor contacts (Carelon, Alacura) as indicated per code.
    SourceLink
    On This Page
    Coverage and Authorization RequirementsCPT / HCPCS / U-code ExamplesHow to Request Prior AuthorizationDefinitions and Notes
    List scope and limitationsPresence of a code on this list does not guarantee coverage; consult member benefit contract for coverage determination
    inv-43: Protein quantity groupings for premix codes
    Protein premix group: 10–51gB4189 premix strength defined as 10–51 grams of protein
    Protein premix group: 52–73gB4193 premix strength defined as 52–73 grams of protein
    Protein premix group: 74–100gB4197 premix strength defined as 74–100 grams of protein
    Protein premix group: >100gB4199 premix strength defined as over 100 grams of protein
    inv-44: Minimum gene counts for specific panels (examples)
    Cardiac/aortic panelsCode 81410 requires sequencing of at least 9 genes for aortic dysfunction/dilation panels
    Cardiac ion channelopathiesCode 81413 requires sequencing of at least 10 genes for cardiac ion channelopathy panels
    Hearing loss panelsCode 81431/81432 require sequencing of at least 60 genes and CNV analysis for STRC and DFNB1 where indicated
    Mitochondrial gene panelsCode 81440 nuclear-encoded mitochondrial gene panels must include analysis of at least 100 genes
    inv-45: Gene panel size examples — ranges from single-gene to whole genome
    Single-gene to small panelsDocument includes single-gene assays and small targeted panels (examples across CPT/PLA entries)
    Mid-size panels (5–50 genes)Codes such as 81450 represent genomic sequence analysis panels of 5–50 genes (hematolymphoid neoplasm panels)
    Large panels to whole genomeU- and specific PLA codes (e.g., 0250U, 0403U) include large panels up to 505 genes and whole-genome sequencing entries
    • Prior authorization assignment: Carelon is the reviewer for numerous advanced imaging and molecular/genetic codes.
    • When Carelon is the assigned vendor for a code, submit prior authorization via Carelon (phone or website).
    Prior Authorization

    Prior authorization required — selected codes

    Selected advanced imaging and related procedure codes require prior authorization. Review the Medical/Surgical Procedures Requiring Prior Authorization list to confirm vendor assignment and authorization requirement before scheduling or billing.

    • Examples of selected advanced imaging codes requiring prior authorization (vendor shown where assigned): 73206, 73218, 73219, 73220, 73221, 73222 — Carelon listed.
    • Many additional CPT codes in the Advanced Imaging/Radiology, Cardiology group are subject to prior authorization; confirm per the searchable list.
    Prior Authorization

    PET imaging prior authorization

    PET imaging CPT codes require prior authorization and are assigned to Carelon for review. Submit prior authorization requests to Carelon for PET studies.

    • PET codes requiring prior authorization include (examples): 78429, 78430, 78431, 78432, 78433, and 78811–78816 — Carelon is assigned.
    • Also see tomographic SPECT/PET codes (78830–78832) with Carelon assignment.
    Prior Authorization

    Echocardiography and related advanced imaging prior authorization

    Echocardiography and other cardiac imaging CPT codes require prior authorization through Carelon. This includes transthoracic, transesophageal, Doppler, stress echocardiography, and related contrast or monitoring codes.

    • Echocardiography/cardiac imaging codes assigned to Carelon include (examples): 93303–93308, 93312–93317, 93320, 93321, 93325, 93350–93352, 93351 — prior authorization via Carelon.
    • Use Carelon for authorization of echocardiography procedures, including studies performed at rest, stress, with contrast, or transesophageal approaches.
    Prior Authorization

    Advanced imaging / MEG / CT / MRI prior authorization

    Advanced imaging (CT/MRI), magnetoencephalography (MEG), and related advanced procedures listed require prior authorization and are routed to Carelon when indicated. Some temporary codes have notes for future effective or removal dates — confirm the code-specific entry in the searchable list.

    • MEG codes 95965 and 95966 — Carelon assigned; add effective 1/1/2026 noted for these codes.
    • Examples of advanced imaging codes assigned to Carelon include 0042T (remove effective 4/1/2026) and 0633T; verify effective dates in the list.
    Prior Authorization

    Cardiology / ENT procedures prior authorization assignments

    Certain cardiology and ENT surgical procedure codes are assigned to BCBSTX (not Carelon) for prior authorization processing. Confirm vendor assignment per code in the searchable list before initiating authorization.

    • Examples assigned to BCBSTX: 36516, S2120, 30120, 30400, 30410, 30420 — these surgical/cardiology/ENT codes show BCBSTX as the authorization routing.
    • If BCBSTX is listed for a code, follow BCBSTX prior authorization process (Blue ApprovrSM, phone, or PDF instructions).
    Prior Authorization

    Home infusion / enteral nutrition prior authorization codes

    Home infusion and enteral nutrition HCPCS codes require prior authorization and many are routed to BCBSTX for processing. Submit prior authorization using the plan's standard channels when BCBSTX is listed, or follow vendor routing if another vendor is assigned.

    • Home infusion/enteral codes requiring prior authorization include (examples): B4103, B4104, B4149, B4150, B4152–B4154 — BCBSTX listed as reviewer for these HCPCS codes.
    • Home infusion per diem codes S9339–S9341 are listed and require prior authorization; drugs and nursing visits are coded separately.
    • Transport and medical transportation codes (A0430, S9960) route to Alacura when noted.
    Prior Authorization

    Molecular genetic and specialty panel prior authorization routing

    Molecular genetic and laboratory testing CPT, PLA and U-codes listed require prior authorization. Carelon is the reviewer for many of these tests — submit prior authorization requests to Carelon when they are the assigned vendor.

    • Selected molecular genetic CPT examples assigned to Carelon: 81120–81121, 81162–81163, 81175–81182, 81229–81233, 81254–81256, 81319–81324, 81350–81357, 81405–81408, 81450–81456, 81462–81464, 81522–81525, 81529, 81558, 81595.
    • Specialty panels and newer PLA/U-codes (0001U, 0004M, 0005U, 0006M, 0007M, 0011M, 0030U–0045U, 0131U–0132U, 0170U–0171U, 0203U, 0205U, 0286U–0297U, 0401U–0405U, 0422U–0424U, 0469U, 0471U, 0473U–0474U, 0403U, 0422U, 0473U etc.) are shown with Carelon assignment; some include notes to add or remove effective dates (see list).
    • Future effective/removal notes: codes such as 95965/95966 (add effective 1/1/2026), 0042T and certain U-codes (remove effective 4/1/2026), and 81354 / 81524 (add effective 4/1/2026) are flagged — verify timing on the code-specific entry.
    No coverage guarantee
    Presence on the list does not necessarily indicate coverage under a member's contract; consult benefit booklet
    inv-74: Carelon — assigned prior authorization vendor for many advanced imaging codes shown
    Carelon roleCarelon is assigned as the prior authorization vendor for many advanced imaging CPT codes shown (examples throughout imaging sections)
    Examples of assignmentMultiple imaging codes (e.g., 73206, 75573, 76376) are annotated with 'Carelon' in the list
    Routing implicationProviders must submit prior authorization requests to Carelon for codes mapped to that vendor
    inv-75: 3D rendering / image postprocessing — billable when indicated
    Billable when indicated3D rendering with interpretation and image postprocessing (e.g., CPT 76376/76377) is listed and billable when indicated
    Vendor mappingThese 3D rendering/postprocessing codes are mapped to Carelon for prior authorization
    Service categoryAppears under Advanced Imaging/Radiology service category alongside imaging CPT codes
    inv-76: Carelon — designated prior authorization vendor referenced for processing authorizations
    Carelon designated reviewerCarelon is identified repeatedly as the designated prior authorization vendor for many listed procedures and tests
    Multiple sectionsCarelon mapping appears across imaging, molecular genetic testing, and other sections
    Provider actionSubmit prior authorization requests to Carelon where the code is annotated with 'Carelon'
    inv-75: Service categories shown alongside CPT codes
    Service categories shownService categories (e.g., Advanced Imaging/Radiology, Cardiology) are listed alongside CPT codes to indicate clinical area
    ExamplesImaging and cardiology categories repeatedly annotated in imaging CPT groups
    Use for routingService category helps identify appropriate clinical area and vendor mapping
    inv-78: Carelon (single-token reference)
    CarelonCarelon
    UsageSingle-token reference used throughout the document to indicate the assigned prior authorization vendor
    ImplicationCodes annotated with 'Carelon' must be routed to that vendor for prior authorization processing
    inv-79: BCBSTX — Blue Cross Blue Shield of Texas assigned as authorization manager for certain codes
    BCBSTX assignmentBCBSTX (Blue Cross Blue Shield of Texas) is identified as the authorization manager for certain codes (e.g., B4103, S2120, 36516)
    Provider routingSome home infusion and procedural codes are mapped to BCBSTX rather than external vendors
    Document noteMapping appears inline next to specific HCPCS/CPT entries in the list
    inv-80: Enteral formula — definition and variants
    DefinitionEnteral formula: nutrition administered through an enteral feeding tube; unit definitions provided (e.g., 500 mL = 1 unit; 100 kcal = 1 unit for some products)
    VariantsIncludes nutritionally complete, incomplete/modular, blenderized natural foods, calorically dense (≥1.5 kcal/mL), pediatric/adult variants
    Coding examplesExamples shown include B4103, B4149, B4150, B4152 with unit conversion notes
    inv-81: Parenteral nutrition — definition
    DefinitionParenteral nutrition: intravenous nutrition solutions including amino acids, dextrose, lipids, electrolytes, trace elements and vitamins; provided as homemix or premix
    Premix protein groupingsPremix codes specify protein amounts (10–51g, 52–73g, 74–100g, >100g) as shown for B4189, B4193, B4197, B4199
    ExamplesHCPCS examples include B4164, B4189, B4193, B4197, B4199
    inv-82: Home infusion per diem — definition and components
    Per diem bundleHome infusion per diem codes represent a bundled daily rate including administrative services, professional pharmacy services, care coordination, and necessary supplies/equipment; drugs and nursing visits are coded separately
    ExamplesS9340, S9341, S9364, S9368 and related S-codes are listed as per diem home infusion services
    Billing noteDo not bill per diem codes with separate per-hour codes; follow coding notes in the list
    inv-83: Home Infusion Therapy / Home Injectable Therapy — descriptor mapping to multiple S-codes
    Descriptor mappingHome Infusion Therapy / Home Injectable Therapy services are represented by multiple S-codes describing administrative services, professional pharmacy services, care coordination, and supplies/equipment; drugs and nursing visits coded separately
    Per diem examplesS9340, S9341, S9364 and other S-codes shown with per diem descriptions
    Use caseThese S-codes identify bundled home infusion services to be routed per mapping (BCBSTX in many entries)
    inv-84: Medical Transportation (Fixed Wing) — codes A0430, S9960 referenced
    Codes referencedFixed-wing medical transportation codes referenced include A0430 and S9960
    Mapping/vendorA0430 and S9960 entries show vendor mapping (e.g., Alacura/BCBSTX as annotated)
    DefinitionRepresents nonemergency fixed-wing ambulance transport (per-chunk description)
    inv-85: Molecular Genetic Lab Testing — CPT codes 81120-81187 mapping to vendor 'Carelon'
    CPT range mappingMolecular Genetic Lab Testing entries cover CPT-style codes in the 81120–81187 range and map many entries to Carelon for prior authorization
    ExamplesExamples include 81162 (BRCA1/2 full sequence and duplication/deletion) and numerous other gene-specific analyses
    Routing noteMolecular genetic CPT codes in this range are annotated with vendor mapping for authorization processing
    inv-86: Carelon — designated prior authorization vendor for listed molecular genetic tests
    Carelon assignedCarelon is repeatedly identified as the designated prior authorization reviewer for the listed molecular genetic tests and U-codes
    Sections referencedCarelon mapping appears in CPT 811xx–814xx ranges and across U-code entries (e.g., 0037U, 0048U, 0403U)
    Provider actionSubmit prior authorization requests for listed molecular/genetic tests to Carelon where annotated
    inv-87: Category label used repeatedly to identify genetic analysis services
    Category labelThe label 'Molecular Genetic Lab Testing' is used repeatedly to identify genetic analysis services mapped to individual codes
    Scope examplesApplied to gene-specific tests (BRCA, FLT3, HBA1/HBA2), procedure-level panels and U-code assays
    Document presenceThis category header appears in multiple sections of the code list
    inv-88: Comparative STR analysis — definition
    Comparative STR analysisComparative analysis using short tandem repeat (STR) markers for patient and comparative specimens (e.g., pre-transplant recipient and donor) is described (CPT 81266, 81269, etc.)
    Use casesIncludes zygosity testing, maternal cell contamination checks, and transplant donor/recipient comparisons
    Coding examplesCPT 81266 and 81269 entries reference comparative STR analysis with Carelon mapping
    inv-89: MSI analysis — microsatellite instability analysis definition
    MSI analysis definitionMSI (microsatellite instability) analysis assesses markers for mismatch repair deficiency and may include comparison of neoplastic and normal tissue if performed (e.g., CPT 81301)
    Clinical contextUsed in tumor profiling and Lynch syndrome–related assessments as annotated in molecular sections
    Vendor mappingMSI analyses listed are mapped to Carelon for prior authorization where indicated
    inv-90: Molecular Pathology Procedure Levels — Levels 1-6 explanation
    Procedure level scaleMolecular Pathology Procedure Levels (81400–81405) describe increasing complexity from Level 1 (single variant detection) up to Level 6 (analysis of 6–10 exons or regional arrays)
    ExamplesLevel descriptions include examples such as single SNP detection (Level 1) through multi-exon or regional arrays (Level 6)
    ImplicationLevels guide coding and prior authorization expectations for molecular pathology services
    inv-91: Carelon reference (supporting)
    Carelon as reviewerCarelon is referenced across molecular sections as the prior authorization/review entity for many molecular/genetic test codes
    Multiple code typesCarelon mapping applies to CPT, PLA, and U-code entries throughout the molecular testing sections
    Submission expectationProviders should route authorization requests for annotated tests to Carelon unless another vendor is specified
    inv-92: Genomic Sequence Analysis Panel must include sequencing of specified minimum number of genes for indicated hereditary condition
    Genomic Sequence Analysis Panel requirementGenomic sequence analysis panels for specified hereditary conditions must include sequencing of the minimum number of genes indicated (examples provided per code, e.g., 81410, 81412)
    Examples includedCodes such as 81410 (aortic dysfunction) and 81412 (Ashkenazi Jewish–associated disorders) specify minimum gene counts in the list
    Carelon mappingThese panel requirements are annotated alongside vendor mapping to Carelon in the list
    inv-93: Duplication/Deletion Analysis Panel — includes copy number analysis examples
    Duplication/deletion (CNV) panelsDuplication/deletion analysis panels include copy number analysis examples for specific genes (e.g., 81411 for TGFBR1/TGFBR2/MYH11/COL3A1; 81431 includes CNV analyses for STRC and DFNB1)
    ExamplesCPT entries explicitly require duplication/deletion analyses where clinically indicated
    Submission noteThese CNV/dup-del panel analyses are mapped to Carelon for prior authorization in the list
    inv-95: Whole mitochondrial genome — definition
    Whole mitochondrial genomeCPT 81462–81465 describe sequencing of the entire mitochondrial genome for mitochondrial disorders (whole mitochondrial genome analysis)
    Clinical examplesUsed for conditions such as MELAS, MERRF, NARP and other mitochondrial encephalomyopathies as noted
    Vendor mappingThese mitochondrial genome tests are annotated with Carelon for prior authorization processing
    inv-96: Carelon (reference)
    Carelon repeated mappingCarelon is listed repeatedly as the prior authorization/review entity for molecular genetic test codes in multiple sections (CPT, PLA, U-codes)
    ScopeApplies to a broad set of molecular genetic and genomic assays across oncology, hereditary disorders, transplant and pharmacogenomics
    Provider expectationSubmit authorization requests to Carelon for codes annotated with Carelon in the list
    inv-97: Molecular Genetic Lab Testing — includes oncology, hereditary disorder panels, transplant assays, pharmacogenomics
    Included test typesMolecular genetic lab testing entries include oncology panels, hereditary disorder panels, transplant assays, pharmacogenomics and other genomic analyses
    ExamplesEntries reference MRD assays, predictive risk scores, comprehensive genomic profiling, and pharmacogenomic panels (e.g., CYP genes)
    Vendor mappingMany of these tests are routed to Carelon for prior authorization review as annotated
    inv-98: Carelon is the listed prior authorization/review entity for tests in this section
    Carelon as PA/reviewer for tests in this sectionCarelon is the listed prior authorization/review entity for the molecular genetic tests enumerated in the molecular sections
    Wide clinical coverageApplies across oncology, neurology, cardiology, reproductive medicine, transplant and rare disease testing
    Submission routingProviders should follow vendor routing and submit to Carelon where codes are annotated accordingly
    inv-99: Predictive/risk/algorithmic report — tests may report continuous or categorical scores
    Predictive/risk reportsSome tests produce predictive or risk algorithmic reports that may be reported as continuous or categorical scores (examples appear in U-code entries like 0203U, 0289U, 0291U)
    Reporting formatsAlgorithms reported as continuous risk scores or categorical classifications (e.g., low/intermediate/high) depending on assay
    Clinical examplesIncludes ASD predictive probability (0170U), Alzheimer predictive risk (0289U), psychiatry gene expression profiles (0291U)
    inv-100: Molecular genetic lab testing (label)
    Molecular Genetic Lab Testing labelThe document uses 'Molecular Genetic Lab Testing' as a section label to group genetic tests and panel codes throughout the list
    Applies to diverse codesLabel covers CPT, PLA and U-code entries with gene analyses, panels, and algorithmic reports
    Vendor mappingEntries under this label commonly show Carelon as the prior authorization reviewer
    inv-101: Minimal Residual Disease (MRD) — definition
    MRD definitionMinimal Residual Disease (MRD) testing detects low levels of disease post-treatment using patient-specific panels or targeted sequencing and is listed (e.g., 0306U/0307U for baseline and subsequent assessments)
    Use case0306U indicates initial baseline assessment to determine patient-specific panel; 0307U denotes subsequent MRD assessment comparing to prior specimen
    Vendor mappingMRD assays in the list are routed to Carelon as annotated
    inv-103: cfDNA definition — circulating donor- or tumor-derived cell-free DNA quantified by NGS
    cfDNA definitioncfDNA refers to circulating donor- or tumor-derived cell-free DNA quantified by NGS and reported as percent or as detected/not detected (e.g., 0494U donor-derived cfDNA)
    Examples0494U quantifies donor-derived cfDNA for transplant monitoring and reports percentage; prenatal assays report detected/not detected for fetal RHD
    Specimen typeTypically performed on plasma and reported as percentage or qualitative detected/not detected per code descriptions